Avant Diagnostics, Inc Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 5 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-08-23: Reporting owner RUXIN MICHAEL I; Form 4; Security Series A Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-08-20: Reporting owner Busch Jeffrey; Form 4; Security Series A Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-06-12: Reporting owner Busch Jeffrey; Form 3; Security Series A Preferred Stock; Transaction Holding.
- 2018-06-04: Reporting owner Brugmann John Edward; Form 3; Security Series A Preferred Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-08-23 | RUXIN MICHAEL I Director, Officer (Chief Executive Officer) | 4 | Series A Preferred Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $1.00 | 2018-09-11 | |
| 2018-08-20 | Busch Jeffrey Director | 4 | Series A Preferred Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 230,000 owned after | $1.00 | 2018-10-10 | |
| 2018-06-12 holding as of filing | Busch Jeffrey Director | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2018-06-12 | ||
| 2018-06-04 holding as of filing | Brugmann John Edward Director | 3 | Series A Preferred Stock Derivative · Indirect · By spouse. | Holding | no price filed | 2018-06-04 | ||
| 2018-06-04 holding as of filing | Brugmann John Edward Director | 3 | Series B Preferred Stock Derivative · Indirect · By spouse. | Holding | no price filed | 2018-06-04 |